Please join us for the LGC, Biosearch COVID-19 Podcast

The COVID-19 pandemic has forced unprecedented change throughout society, from lockdowns and mask wearing to the rapid marshalling of the molecular diagnostics and therapeutic development communities to counteract this deadly disease. In Countering Covid, a podcast brought to you by LGC, Biosearch Technologies, our goal is to help assay developers, scientists, and clinicians gain behind-the-scenes insight into the technologies around SARS-CoV-2 testing. Through conversations with the scientists that are building, implementing, and reconfiguring technologies to address SARS-CoV-2 challenges, we highlight how, working together, we can make the world a safer place.


Listen: Apple Spotify Amazon Stitcher
01
Focusing on the finer points of the SARS-CoV-2 testing workflow: false positives and false negatives

17 December, 2020 / Understanding misleading COVID-19 test results

Like any diagnostic test, SARS-CoV-2 molecular diagnostic assays are affected by the appearance of false positives and false negative results. In this episode, we speak with qPCR assay, workflow, and measurement experts Jim Huggett, Tania Nolan, and James Grayson about the causes of false positives and false negatives and how to mitigate these misleading events. Along the way we also touch on limits-of-detection, the role of workflow software in supporting the production of reliable results, and important aspects of the qPCR assay that clinicians and assay developers should keep in mind.



listen to episode

Podcast Episdoe Image

02
Insights from an academic clinical research assay developer

22 January, 2021 / Analysis of numerous factors of COVID-19 testing, including test development and tests for different sample types

The sudden onset of the SARS-CoV-2 pandemic forced many academic research labs to pivot to diagnostic testing. In this episode, we speak with Priya Banada, an Assistant Professor at Rutgers New Jersey Medical School, about her experiences pivoting from developing clinical research assays to running diagnostic assays, with added insights from a software vendor’s point-of-view from James Grayson. We also cover the pros and cons of different sample types, viral load, and how more clinicians should be asking to see Ct values.



listen to episode

Podcast Episdoe Image

3
Using artificial intelligence to counter COVID

10 March, 2021

A fairly new technology for medical settings, artificial intelligence (AI) has been critical for enabling deep insights and fast responses to the pandemic. In this podcast, we speak with scientists from three different companies on how they use AI to counter the pandemic, the challenges facing AI in a biomedical setting, and the real advantages that this powerful technology can bring to improve healthcare outcomes. Covering SARS-CoV-2 molecular diagnostic testing, patient management in the hospital, and SARS-CoV-2 diagnostic imaging, our guests bring together an impressive depth of knowledge and range of viewpoints on the implementation of AI in medicine.



listen to episode

Podcast Episdoe Image

Meet our host
Pia Abola, PhD
Pia Abola, PhD, has spent the past ten years providing content marketing for life science companies. Before becoming a marketer she used protein biochemistry and molecular biology to study site-specific recombination, plant-bacteria symbiosis, and signal transduction. She also worked on the human genome sequencing project and and at an anti-viral drug discovery company.

Enabling your rapid response to the pandemic

COVID Resource Hub

Working with you to wield science for a safer world.